[1]
M. Shmela and M. Habbassi, “Overview in EMA and FDA Approved Novel Drugs in the Years 2020, 2021 and 2022”., LJMR, vol. 18, no. 1, pp. 178–192, Jan. 2024, doi: 10.54361/Ljmr18-1.18.